Top 3 TBS articles in Q1 2023
A great number of articles about TBS are published each year. Many peer-reviewed articles about…
ECR Workshop recording now available!
At ECR 2023, Prof. Didier Hans, Prof. Karen Hind and Prof. Giuseppe Guglielmi co-presented a series of…
Medimaps Group presents new AI results at ECR 2023
Medimaps Group presents data showing how new AI approach enhances osteoporosis diagnosis and monitoring at ECR…
Lunch & Learn at ECR 2023
Join us at one of our Lunch & Learn Workshops on March 2nd, 3rd, or…
“¿Que me pasa, doctor?” with Santiago Palacios : bone quantity and bone quality through TBS
Durante la emisión"¿Que me pasa, doctor?", el Doctor Santiago Palacios, Director de la Clínica Palacios…
Osteoporosis: know your risks, test your bones
The incidence of osteoporosis and related fractures is on the rise. As recommended by AARP,…
TOP 10 TBS Articles in 2022
More than 150 articles about TBS were published in 2022. As we are now entering…
Trabecular Bone Score, a new tool to predict fracture risk
There is no doubt that DXA bone densitometry has a significant impact on the diagnosis…
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members
GENEVA--Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone…
TBS Osteo, The Missing Link To Bone Fracture Risk Prediction
BMD is currently the gold standard for the diagnosis of osteoporosis, but clinicians need more…
RSNA Innovation Theater – Rethinking How To Diagnose Osteoporosis
At RSNA 2022, Dr. Lynn Kohlmeier, MD, Director of Spokane Osteoporosis and Endocrine Associates of…
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea’s Leading Bone Densitometry Platform
Medimaps Group Announces Partnership With OSTEOSYS CO., LTD to Bring Trabecular Bone Score to Korea’s…
Webinar – Advances in osteoporosis screening: Finding more patients at risk
We sponsored an AuntMinnie's webinar on advances in osteoporosis screening and finding more patients at…
Book a meeting with Medimaps Group at the 2022 Santa Fe Bone Symposium
Join Medimaps Group (booth #101) at the 2022 Santa Fe Bone Symposium to talk…
Presentation of 2022 ISCD Award-Winning Abstract on TBS and Denosumab
At the 2022 ISCD Annual Meeting, our CEO Prof. Didier Hans presented his award-winning abstract…
Panel Discussion on Integrating TBS into Clinical Practice with Dr. Lewiecki and Dr. Singer
Alongside Medimaps Group, Dr. Lewiecki and Dr. Singer, two world-renowned leaders in the field of…
[PRESS RELEASE]Medical Reimbursement Now Available for Trabecular Bone Score (TBS), an Advanced Medtech Solution with Artificial Intelligence Capabilities, for Osteoporsis Fracture Risk Assessment
GENEVA--MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for the assessment…
[BOOK A MEETING] Join us at the Nevada Clinical Endocrinologists’ Association
Join us at the Nevada Clinical Endocrinologists’ Association in Reno, Nevada on April 2nd, 2022…